(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
Emerging growth company |
Page | |
EXPLANATORY NOTE | |
PART I - FINANCIAL INFORMATION | |
Item 1. Financial Statements | |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
Item 3. Quantitative and Qualitative Disclosures About Market Risk | |
Item 4. Controls and Procedures | |
PART II - OTHER INFORMATION | |
Item 1. Legal Proceedings | |
Item 1A. Risk Factors | |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | |
Item 3. Defaults Upon Senior Securities | |
Item 4. Mine Safety Disclosures | |
Item 5. Other Information | |
Item 6. Exhibits | |
Signatures |
Page | |
Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024 | |
Condensed Consolidated Statements of Operations for the three months ended March 31, 2025 and March 31, 2024 | |
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2025 and March 31, 2024 | |
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and March 31, 2024 | |
Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2025 and March 31, 2024 | |
Notes to the Condensed Consolidated Financial Statements |
March 31, 2025 | December 31, 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ million and $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 15) | |||
Equity: | |||
Preferred stock; $ | |||
Common stock; $ shares outstanding at March 31, 2025 and December 31, 2024, respectively | |||
Deferred shares; € | |||
Treasury stock; at cost; 2024, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three months ended March 31, | |||
2025 | 2024 | ||
Net sales | $ | $ | |
Cost of goods sold | ( | ( | |
Gross profit | |||
Selling, general and administrative expenses | ( | ( | |
Transaction and integration-related expenses associated with the Combination | ( | ( | |
Operating profit | |||
Pension and other postretirement non-service income (expense), net | ( | ||
Interest expense, net | ( | ( | |
Other expense, net | ( | ( | |
Income before income taxes | |||
Income tax expense | ( | ( | |
Net income | |||
Net loss attributable to noncontrolling interests | |||
Net income attributable to common shareholders | $ | $ | |
Basic earnings per share attributable to common shareholders | $ | $ | |
Diluted earnings per share attributable to common shareholders | $ | $ | |
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. |
Three months ended March 31, | |||
2025 | 2024 | ||
Net income | $ | $ | |
Other comprehensive income (loss), net of tax: | |||
Foreign currency translation gain (loss) | ( | ||
Defined benefit pension and other postretirement benefit plans adjustments | ( | ||
Net gain (loss) on cash flow hedging derivatives | ( | ||
Other comprehensive income (loss), net of tax | ( | ||
Comprehensive income | |||
Comprehensive loss attributable to noncontrolling interests | |||
Comprehensive income attributable to common shareholders | $ | $ | |
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. |
Three months ended March 31, | |||
2025 | 2024 | ||
Operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||
Depreciation, depletion and amortization | |||
Cash surrender value increase in excess of premiums paid | ( | ||
Share-based compensation expense | |||
Deferred income tax benefit | ( | ( | |
Pension and other postretirement funding more than cost | ( | ( | |
Other | |||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
Accounts receivable | ( | ( | |
Inventories | ( | ||
Other assets | ( | ( | |
Accounts payable | ( | ( | |
Income taxes | ( | ||
Accrued liabilities and other | ( | ( | |
Net cash provided by operating activities | |||
Investing activities: | |||
Capital expenditures | ( | ( | |
Cash paid for purchase of businesses, net of cash acquired | ( | ||
Other | |||
Net cash used for investing activities | ( | ( | |
Financing activities: | |||
Additions to debt | |||
Repayments of debt | ( | ( | |
Debt issuance costs | ( | ||
Changes in commercial paper, net | |||
Other debt repayments, net | ( | ||
Repayments of finance lease liabilities | ( | ( | |
Tax paid in connection with shares withheld from employees | ( | ||
Purchases of treasury stock | ( | ||
Cash dividends paid to shareholders | ( | ||
Other | |||
Net cash provided by financing activities | |||
Effect of exchange rate changes on cash and cash equivalents | ( | ||
Decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at beginning of period | |||
Cash and cash equivalents at end of period | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest (“NCI”) | Total | |
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of deferred shares by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at March 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest (“NCI”) | Total | |
Balance at December 31, 2023(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | — | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Purchases of treasury stock | — | — | — | ( | — | — | ( | — | ( |
Issuance of common stock | — | — | — | — | — | — | — | — | |
Balance at March 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ |
Three months ended | |
March 31, 2024 | |
Net sales | $ |
Net income attributable to common shareholders |
Three months ended March 31, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | $ | $ | $ | $ | |||
Less segment expenses: | |||||||
Segment cost of goods sold | $( | $( | $( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
$( | $( | $( | $( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended March 31, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | $ | $ | $ | $ | |||
Less segment expenses: | |||||||
Segment cost of goods sold | $( | $( | $( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
$( | $( | $( | $( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | |||||||
Income before income taxes | $ |
Three months ended March 31, | |||
2025 | 2024 | ||
Capital expenditures: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | $ | $ | |
Corporate | |||
Total capital expenditures | $ | $ |
March 31, | December 31, | ||
2025 | 2024 | ||
Assets: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | $ | $ | |
Corporate(1) | |||
Total assets | $ | $ |
Three months ended March 31, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ |
Three months ended March 31, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ |
Contract Assets (Short-Term) | Contract Liabilities (Short-Term) | ||
Beginning balance - January 1, 2025 | $ | $ | |
Decrease | ( | ( | |
Ending balance - March 31, 2025 | $ | $ |
Three months ended March 31, | |||
2025 | 2024 | ||
Transaction-related costs associated with the Combination | $( | $( | |
Integration-related costs associated with the Combination | ( | ||
Total transaction and integration-related costs associated with the Combination | $( | $( |
March 31, | December 31, | ||
2025 | 2024 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable, net | $ | $ |
March 31, | December 31, | ||
2025 | 2024 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ |
March 31, | December 31, | ||
2025 | 2024 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction in progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and amortization | ( | ( | |
Property, plant and equipment, net, excluding forestlands | $ | $ | |
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ |
Three months ended March 31, | |||
2025 | 2024 | ||
Interest expense | $( | $( | |
Interest income | |||
Interest expense, net | $( | $( |
March 31, 2025 | December 31, 2024 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ |
Level 1 | Level 2 | ||||||
March 31, | December 31, | March 31, | December 31, | ||||
2025 | 2024 | 2025 | 2024 | ||||
Assets | |||||||
Other Investments: | |||||||
Listed | $ | $ | $ | $ | |||
Unlisted | |||||||
Derivatives in cash flow hedging relationships | |||||||
Derivatives not designated as hedging instruments | |||||||
Assets measured at fair value | $ | $ | $ | $ | |||
Liabilities | |||||||
Derivatives in cash flow hedging relationships | $ | $ | $ | $ | |||
Derivatives not designated as hedging instruments | |||||||
Liabilities measured at fair value | $ | $ | $ | $ |
Receivable from financial institutions at December 31, 2024 | $ |
Receivables sold to the financial institutions and derecognized | ( |
Receivables collected by financial institutions | |
Cash payments to financial institutions | ( |
Receivable from financial institutions at March 31, 2025 | $ |
March 31, | December 31, | ||
2025 | 2024 | ||
$ | $ | $ | |
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
$ | |||
$ | |||
$ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
Commercial paper | |||
Vendor financing and commercial card programs | |||
Term loan facilities | |||
Bank loans | |||
Finance lease obligations | |||
Bank overdrafts | |||
Total debt, excluding debt issuance costs | |||
Debt issuance costs | ( | ( | |
Total debt | |||
Less: Current portion of debt | ( | ( | |
Non-current debt due after one year | $ | $ |
Defined Benefit Pension Plans | |||||||
U.S. Plans | Non-U.S. Plans | ||||||
Three months ended March 31, | Three months ended March 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Service cost | $ | $ | $ | $ | |||
Interest cost | |||||||
Expected return on assets | ( | ( | ( | ( | |||
Amortization of: | |||||||
Net actuarial loss | |||||||
Prior service credit | ( | ||||||
Net periodic benefit (income) cost | $( | $ | $ | $ |
Other Postretirement Benefit Plans | |||
Three months ended March 31, | |||
2025 | 2024 | ||
Service cost | $ | $ | |
Interest cost | |||
Net periodic benefit cost | $ | $ |
Three months ended March 31, | |||
2025 | 2024 | ||
Defined Benefit Pension Plans Contributions | $ | $ | |
Other Postretirement Benefit Plans Contributions |
Three months ended March 31, | |||
2025 | 2024 | ||
Numerator: | |||
Net income attributable to common shareholders | $ | $ | |
Denominator: | |||
Basic weighted average shares outstanding | |||
Effect of dilutive share options | |||
Diluted weighted average shares outstanding | |||
Basic earnings per share attributable to common shareholders | $ | $ | |
Diluted earnings per share attributable to common shareholders | $ | $ |
March 31, | December 31, | ||
2025 | 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Postretirement Plans | Other Reserves(1) | Total(2) | |
Balance at December 31, 2023 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ||||
Balance at March 31, 2024 | $ | $ | $ | $( | $ |
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | ( | ||
Balance at March 31, 2025 | $ | $ | $ | $( | $ |
Three months ended March 31, | |||||||
2025 | 2024 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain (loss) | $ | $ | $ | $( | $ | $( | |
Defined benefit pension and other post-retirement benefit plans: | |||||||
Net actuarial loss arising during period | ( | ( | |||||
Amortization and settlement recognition of net actuarial loss | ( | ||||||
Amortization of prior service credit | ( | ( | |||||
Foreign currency (loss) gain - pensions | ( | ( | |||||
Derivatives: | |||||||
Changes in fair value of cash flow hedges | ( | ( | |||||
Consolidated other comprehensive income (loss) | ( | ( | ( | ||||
Less: Other comprehensive (income) loss attributable to noncontrolling interests | |||||||
Other comprehensive income (loss) attributable to common shareholders | $ | $ | $ | $( | $( | $( |
Three months ended March 31, | |||
2025 | 2024 | ||
Net sales | $7,656 | $2,930 | |
Cost of goods sold | (6,079) | (2,220) | |
Gross profit | 1,577 | 710 | |
Selling, general and administrative expenses | (988) | (380) | |
Transaction and integration-related expenses associated with the Combination | (36) | (23) | |
Operating profit | 553 | 307 | |
Pension and other postretirement non-service income (expense), net | 9 | (10) | |
Interest expense, net | (167) | (25) | |
Other expense, net | (5) | (5) | |
Income before income taxes | 390 | 267 | |
Income tax expense | (8) | (76) | |
Net income | 382 | 191 | |
Net loss attributable to noncontrolling interests | 2 | — | |
Net income attributable to common shareholders | $384 | $191 |
Three months ended March 31, | |||
2025 | 2024 | ||
Net sales (aggregate):(1) | |||
North America | $4,669 | $412 | |
Europe, MEA and APAC | 2,582 | 2,194 | |
LATAM | 513 | 341 | |
Segment Adjusted EBITDA: | |||
North America | $785 | $59 | |
Europe, MEA and APAC | 389 | 385 | |
LATAM | 115 | 54 |
Three months ended March 31, | ||
($ in millions) | ||
2025 | 2024 | |
Net cash provided by operating activities | $235 | $42 |
Net cash used for investing activities | $(476) | $(207) |
Net cash provided by financing activities | $151 | $— |
Three months ended March 31, | |||
($ in millions) | |||
2025 | 2024 | ||
Net income | $382 | $191 | |
Income tax expense | 8 | 76 | |
Depreciation, depletion and amortization | 603 | 148 | |
Transaction and integration-related expenses associated with the Combination | 36 | 23 | |
Interest expense, net | 167 | 25 | |
Pension and other postretirement non-service (income) expense, net | (9) | 10 | |
Share-based compensation expense | 43 | 15 | |
Other expense, net | 5 | 5 | |
Other adjustments | 17 | (18) | |
Adjusted EBITDA | $1,252 | $475 |
Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs | |||
January 1, 2025 – January 31, 2025 | — | $— | — | — | |||
February 1, 2025 – February 28, 2025 | 217,536 | 54.65 | — | — | |||
March 1, 2025 – March 31, 2025 | — | — | — | — | |||
Total | 217,536 | — |
Exhibit Number | Description of Exhibit | ||
3.1 | |||
10.1† | |||
10.2† | |||
10.3† | |||
31.1† | |||
31.2† | |||
32†* | |||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Smurfit Westrock plc | ||
Dated: May 9, 2025 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Group Chief Executive Officer | |
(Principal Executive Officer) |
Smurfit Westrock plc | ||
Dated: May 9, 2025 | /s/ Ken Bowles | |
Name: | Ken Bowles | |
Title: | Executive Vice President and Group Chief Financial Officer | |
(Principal Financial Officer) |